Opal Therapeutics is the go-to partner for uterine organoids and disease modeling in women’s health. We build high-fidelity, patient-derived models of endometriosis and fibroids to help biotech and pharma accelerate discovery and de-risk development. From compound screening to biomarker validation, our platform delivers the human data preclinical studies have been missing
| Website | https://www.opaltherapeutics.com/ |
| Employees | 7 (5 on RocketReach) |
| Founded | 2023 |
| Address | 135 Mississippi St, San Francisco, California 94107, US |
| Industry | Biotechnology Research |
| Keywords | Gynecology, Reproductive Health, Womens Health, Womens Reproductive Health, Reproductive Medicine, Obgyn, Womens Health Research, Fertility Treatment, Therapeutic Solutions, Infertility Treatment, Pharmaceutical Research, Drug Development, Biotechnology, Hormone Therapy, Ovarian Health, Uterine Health, Clinical Trials, Medical Research, Menopause Treatment |
| Competitors | Gilead Sciences, Amgen, AbbVie, Biogen, Regeneron, Vertex Pharmaceuticals, Sanofi, Roche, Novartis, Lilly India +51 more (view full list) |
Looking for a particular Opal Therapeutics employee's phone or email?
Morgan Stanton is the CEO of Opal Therapeutics.
5 people are employed at Opal Therapeutics.
Opal Therapeutics is based in San Francisco, California.